Our work observed the serum levels of Slit2 in ApcMin/+ mice at the proliferative stage, adenoma stage, and carcinoma stage, and found that the concentration of Slit2 was increased in the serum of all development stages compared with that in wildtype mice. Here, SLIT2 is linked to adenoma.